The humble mackerel on your toast might be doing more for your memory than you realise. A new BBC Ideas film, part of the Just One Thing series on iPlayer, distils decades of nutritional neuroscience into a clear verdict: regular consumption of oily fish remains one of the most evidence-backed dietary strategies for long-term brain health. But the mechanisms are more nuanced — and the benefits more specific — than the familiar “brain food” label suggests.
The omega-3 factor: DHA takes centre stage
At the heart of the conversation sits docosahexaenoic acid, or DHA. This long-chain omega-3 fatty acid isn’t merely “good for you” in a vague wellness sense; it is a structural cornerstone of neuronal membranes. The human brain is roughly 60% fat by dry weight, and DHA accounts for up to 97% of the omega-3s found there. It influences membrane fluidity, receptor function, and the very architecture of synapses.
Unlike alpha-linolenic acid (ALA) from plant sources such as flaxseed or walnuts, DHA from marine sources — salmon, sardines, herring, anchovies — is bioavailable in the form the brain actually uses. Conversion of ALA to DHA in humans is notoriously inefficient, often below 5%. That metabolic bottleneck makes direct dietary intake critical.
Inflammation, vascular health, and the silent drivers of decline
Cognitive ageing isn’t just about neurons dying. It’s about chronic, low-grade inflammation — “inflammageing” — and the slow erosion of cerebral blood flow. Omega-3s, particularly eicosapentaenoic acid (EPA) alongside DHA, modulate inflammatory pathways by competing with arachidonic acid for enzymatic conversion, yielding less potent eicosanoids. They also improve endothelial function, supporting the microvasculature that feeds the hippocampus, the brain’s memory hub.
Population studies consistently link higher blood levels of omega-3s with larger hippocampal volumes and slower rates of cortical thinning. Randomised controlled trials, while mixed, show the clearest benefits in older adults with mild cognitive impairment or low baseline intake — precisely the groups most likely to respond.
The supplement question: food first, but context matters
The film doesn’t shy from the supplement debate. Fish oil capsules are a multi-billion-pound industry, yet meta-analyses reveal a stark pattern: whole fish outperforms isolated oils in observational data. The reason likely lies in the matrix — selenium, iodine, vitamin D, taurine, and high-quality protein all travel with the omega-3s in a fillet of wild salmon. These co-factors may enhance absorption, reduce oxidation, or exert independent neuroprotective effects.
That said, for those who cannot or will not eat fish — due to allergy, ethics, or access — high-quality algal oil provides a direct vegan source of DHA. The key is dosage: trials suggesting cognitive benefit typically use 500–1,000 mg of combined EPA/DHA daily, far above the 250 mg often found in standard capsules.
Mercury, sustainability, and making it practical
Concerns about heavy metals are valid but often overstated for the species that matter most. Small, short-lived fish — sardines, anchovies, mackerel (Atlantic, not king), herring — sit low on the food chain, accumulating minimal mercury while delivering maximal omega-3s. They are also among the most sustainable choices, often certified by the Marine Stewardship Council.
Two portions a week — one oily — remains the NHS guideline. That’s a tin of sardines on wholegrain toast and a grilled salmon fillet. Simple. Affordable. Achievable.
Why it Matters
Dementia rates are projected to triple globally by 2050, and no disease-modifying drug has yet delivered a cure. In that vacuum, prevention becomes paramount — and nutrition is the lever most people can actually pull. Oily fish isn’t a magic bullet, but it is a rare intervention with mechanistic plausibility, epidemiological consistency, and a safety profile that makes it a cornerstone of any serious brain-health strategy. The science isn’t settled on every detail, but the weight of evidence is heavy enough to act on.
